Individual investigator profiles of biospecimen use in cancer research

Biopreservation and Biobanking

Volumn 12, Issue 3, 2014, Pages 192-198

  Braun, Lauren ^a   Lesperance, Maria ^a   Mes Massons, Anne Marie ^b,c,d   Tsao, Ming S ^e   Watson, Peter H ^a  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^c Institut du Cancer de Montreal   (Canada)

^d UNIVERSITÉ DE MONTRÉAL   (Canada)

^e UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOSPECIMEN; BREAST CANCER; CANCER RESEARCH; CAREER; COHORT ANALYSIS; HUMAN; LUNG CANCER; MEDICAL ETHICS; OVARY CANCER; PRIORITY JOURNAL; PUBLICATION; SYSTEMATIC REVIEW; TRANSLATIONAL RESEARCH; TUMOR BIOPSY; BIBLIOGRAPHIC DATABASE; HEALTH CARE FACILITY; LABORATORY DIAGNOSIS; MEDICAL RESEARCH; NEOPLASM; PATHOLOGY; PERSONNEL; STATISTICS AND NUMERICAL DATA; TRENDS;

BIOLOGICAL SPECIMEN BANKS; BIOMEDICAL RESEARCH; DATABASES, BIBLIOGRAPHIC; HUMANS; NEOPLASMS; RESEARCH PERSONNEL; SPECIMEN HANDLING;

EID: 84903269024     PISSN: 19475535     EISSN: 19475543     Source Type: Journal    
DOI: 10.1089/bio.2013.0092     Document Type: Article

References (17)

1. Hainaut P, Caboux E, Bevilacqua G, et al. Pathology as the cornerstone of human tissue banking: European Consensus Expert Group Report. Biopreserv Biobank 2009;7:157-160.
2. Vaught J, Kelly A, Hewitt R. A review of international biobanks and networks: Success factors and key benchmarks. Biopreserv Biobank 2009;7:143-150.
3. Canadian Tumour Repository Network. Biopreserv Biobank 2010;8:181-185.
4. Hewitt R, Watson P. Defining biobank. Biopreserv Biobank 2013;11:309-315.
5. Zika E, Paci D, Braun A, et al. A European survey on biobanks: Trends and issues. Public Health Genom 2011; 14:96-103.
6. Henderson GE, Cadigan RJ, Edwards TP, et al. Characterizing biobank organizations in the U.S.: Results from a national survey. Genome Med 2013;5:3.
7. Moore HM, Kelly A, Jewell SD, et al. Biospecimen reporting for improved study quality. Biopreserv Biobank 2011;9:57-70.
8. Cheah S, Dee S, Cole A, Matzke L, O'Donoghue S, Watson PH. An online tool for improving biospecimen data element reporting. Biopreserv Biobank 2012;10:501-510.
9. Gonzalez-Sanchez MB, Lopez-Valeiras E, Morente MM, Ferna'ndez Lago O. Cost model for biobanks. Biopreserv Biobank 2013;11:272-277.
10. Vaught J, Rogers J, Myers K, et al. An NCI perspective on creating sustainable biospecimen resources. J Natl Cancer Inst Monogr 2011;2011:1-7.
11. Simeon-Dubach D, Watson P. Biobanking 3.0: Evidence based and customer focused biobanking. Clin Biochem 2014;47:300-308.
12. Carter A, Betsou F. Quality assurance in cancer biobanking. Biopreserv Biobank 2011;9:157-163.
13. Nussbeck SY, Benson EE, Betsou F, Guadagni F, Lehmann S, Umbach N. Is there a protocol for using the SPREC? Biopreserv Biobank 2013;11:260-266.
14. Hughes SE, Barnes RO, Watson PH. Biospecimen use in cancer research over two decades. Biopreserv Biobank 2010;8:89-97.
15. Cole A, Cheah S, Dee S, Hughes S, Watson PH. Biospecimen use correlates with emerging techniques in cancer research: Impact on planning future biobanks. Biopreserv Biobank 2012;10:518-525.
16. Simeon-Dubach D, Burt AD, Hall PA. Quality really matters: The need to improve specimen quality in biomedical research. J Pathol 2012;61:1003-1005.
17. Simeon-Dubach D, Perren A. Better provenance for biobank samples. Nature 2011;475:454-455.